Fund shareholders of Gilead Sciences Inc
ISIN US3755581036 · United States · LEI 549300WTZWR07K8MNV44
- Fund shareholders
- 1,502
- Of which ETFs
- 400 1,102 other funds
- Value held
- 70.2B $ 11.2B SEK · 134.3M €
- Share of capital
- 41.5 % of 1.2B shares on Jul 31, 2026
1,502 funds hold this company. This table lists the 1,492 that declare it in a regulatory filing. The other 10 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 39,428,113 | 5.5B $ | 0.28 % | 3.18 % | as of Mar 31, 2026 ↗ |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 31,528,197 | 4.4B $ | 0.31 % | 2.54 % | as of Mar 31, 2026 ↗ |
| Invesco QQQ Trust, Series 1 Invesco QQQ Trust, Series 1 | 26,151,783 | 3.6B $ | 0.98 % | 2.11 % | as of Mar 31, 2026 ↗ |
| Dodge & Cox Stock Fund Dodge & Cox Funds | 18,093,312 | 2.5B $ | 2.20 % | 1.46 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P 500 ETF iShares Trust | 15,956,074 | 2.2B $ | 0.31 % | 1.29 % | as of Mar 31, 2026 ↗ |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 15,789,209 | 2.4B $ | 0.31 % | 1.27 % | as of Feb 28, 2026 ↗ |
| Income Fund of America Income Fund of America | 15,498,550 | 2B $ | 1.38 % | 1.25 % | as of Apr 30, 2026 ↗ |
| JPMorgan Large Cap Growth Fund JPMorgan Trust II | 12,360,249 | 1.7B $ | 1.60 % | 1.00 % | as of Mar 31, 2026 ↗ |
| Washington Mutual Investors Fund Washington Mutual Investors Fund | 11,903,058 | 1.6B $ | 0.73 % | 0.96 % | as of Apr 30, 2026 ↗ |
| American Mutual Fund American Mutual Fund | 11,675,383 | 1.5B $ | 1.33 % | 0.94 % | as of Apr 30, 2026 ↗ |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 11,482,635 | 1.6B $ | 0.71 % | 0.93 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 10,331,523 | 1.4B $ | 0.91 % | 0.83 % | as of Mar 31, 2026 ↗ |
| American Balanced Fund American Balanced Fund | 9,837,660 | 1.4B $ | 0.52 % | 0.79 % | as of Mar 31, 2026 ↗ |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 9,028,573 | 1.3B $ | 3.26 % | 0.73 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 6,995,572 | 975M $ | 0.31 % | 0.56 % | as of Mar 31, 2026 ↗ |
| VANGUARD DIVIDEND APPRECIATION INDEX FUND VANGUARD SPECIALIZED FUNDS | 6,965,463 | 911.4M $ | 0.73 % | 0.56 % | as of Apr 30, 2026 ↗ |
| Capital Income Builder Capital Income Builder | 6,514,103 | 852.3M $ | 0.67 % | 0.53 % | as of Apr 30, 2026 ↗ |
| VANGUARD EQUITY INCOME FUND VANGUARD FENWAY FUNDS | 6,096,560 | 849.7M $ | 1.36 % | 0.49 % | as of Mar 31, 2026 ↗ |
| VANGUARD HIGH DIVIDEND YIELD INDEX FUND VANGUARD WHITEHALL FUNDS | 4,907,588 | 642.1M $ | 0.68 % | 0.40 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 4,720,956 | 617.7M $ | 0.65 % | 0.38 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ 100 ETF Invesco Exchange-Traded Fund Trust II | 4,719,944 | 703M $ | 0.99 % | 0.38 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 4,549,986 | 677.7M $ | 0.31 % | 0.37 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 4,515,707 | 629.4M $ | 7.75 % | 0.36 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Value Fund, Inc. T. ROWE PRICE VALUE FUND, INC. | 4,127,097 | 575.2M $ | 1.80 % | 0.33 % | as of Mar 31, 2026 ↗ |
| Capital World Growth & Income Fund Capital World Growth & Income Fund | 3,948,215 | 588.1M $ | 0.39 % | 0.32 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 3,726,968 | 555.1M $ | 2.74 % | 0.30 % | as of Feb 28, 2026 ↗ |
| Columbia Dividend Income Fund COLUMBIA FUNDS SERIES TRUST I | 3,695,871 | 550.5M $ | 1.15 % | 0.30 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 3,149,952 | 469.2M $ | 8.77 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Invesco S&P 500 Quality ETF Invesco Exchange-Traded Fund Trust | 2,998,708 | 392.4M $ | 2.27 % | 0.24 % | as of Apr 30, 2026 ↗ |
| Schwab S&P 500 Index Fund SCHWAB CAPITAL TRUST | 2,752,536 | 360.1M $ | 0.26 % | 0.22 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) ETF SPDR SERIES TRUST | 2,608,221 | 363.5M $ | 0.31 % | 0.21 % | as of Mar 31, 2026 ↗ |
| MFS Growth Fund MFS Series Trust II | 2,601,765 | 387.5M $ | 0.97 % | 0.21 % | as of Feb 28, 2026 ↗ |
| Pacer US Cash Cows 100 ETF Pacer Funds Trust | 2,547,791 | 333.4M $ | 1.83 % | 0.21 % | as of Apr 30, 2026 ↗ |
| iShares Core Dividend Growth ETF iShares Trust | 2,357,032 | 308.4M $ | 0.78 % | 0.19 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,319,628 | 345.5M $ | 0.28 % | 0.19 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 2,244,835 | 312.9M $ | 0.93 % | 0.18 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 Value ETF iShares Trust | 2,090,068 | 291.3M $ | 0.42 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Fidelity OTC Portfolio Fidelity Securities Fund | 2,073,962 | 271.4M $ | 0.67 % | 0.17 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 2,034,836 | 283.6M $ | 2.60 % | 0.16 % | as of Mar 31, 2026 ↗ |
| Fidelity Balanced Fund Fidelity Puritan Trust | 1,969,157 | 293.3M $ | 0.47 % | 0.16 % | as of Feb 28, 2026 ↗ |
| Investment Co of America Investment Co of America | 1,947,854 | 271.5M $ | 0.16 % | 0.16 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Dividend Growth Fund, Inc. T. ROWE PRICE DIVIDEND GROWTH FUND, INC. | 1,933,095 | 269.4M $ | 1.19 % | 0.16 % | as of Mar 31, 2026 ↗ |
| iShares MSCI USA Momentum Factor ETF iShares Trust | 1,910,596 | 250M $ | 1.03 % | 0.15 % | as of Apr 30, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 1,882,016 | 2.5B SEK | 0.19 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,836,693 | 273.6M $ | 0.28 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Asset Allocation Fund AMERICAN FUNDS INSURANCE SERIES | 1,754,140 | 244.5M $ | 0.93 % | 0.14 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 1,736,422 | 258.6M $ | 3.96 % | 0.14 % | as of Feb 27, 2026 ↗ |
| VANGUARD WELLESLEY INCOME FUND VANGUARD WELLESLEY INCOME FUND | 1,732,963 | 241.5M $ | 0.51 % | 0.14 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price U.S. Large-Cap Core Fund, Inc. T. ROWE PRICE U.S. LARGE-CAP CORE FUND, INC. | 1,674,268 | 233.3M $ | 1.41 % | 0.14 % | as of Mar 31, 2026 ↗ |
| WisdomTree U.S. Quality Dividend Growth Fund WisdomTree Trust | 1,672,161 | 233M $ | 1.52 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Disciplined Value Fund John Hancock Funds III | 1,656,471 | 230.9M $ | 1.36 % | 0.13 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 1,631,838 | 227.4M $ | 0.18 % | 0.13 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 1,558,343 | 217.2M $ | 0.27 % | 0.13 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD DIVIDEND AND GROWTH FUND HARTFORD MUTUAL FUNDS, INC | 1,494,084 | 195.5M $ | 1.07 % | 0.12 % | as of Apr 30, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 1,478,015 | 206M $ | 0.78 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 1,469,973 | 219M $ | 0.67 % | 0.12 % | as of Feb 28, 2026 ↗ |
| VANGUARD LARGE-CAP INDEX FUND VANGUARD INDEX FUNDS | 1,457,337 | 203.1M $ | 0.32 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Equity-Income Fund Fidelity Devonshire Trust | 1,455,374 | 190.4M $ | 1.66 % | 0.12 % | as of Apr 30, 2026 ↗ |
| iShares MSCI USA Min Vol Factor ETF iShares Trust | 1,434,851 | 187.7M $ | 0.82 % | 0.12 % | as of Apr 30, 2026 ↗ |
| iShares S&P 500 Growth ETF iShares Trust | 1,407,912 | 196.2M $ | 0.32 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 1,399,176 | 195M $ | 0.83 % | 0.11 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 1,351,957 | 188.4M $ | 0.17 % | 0.11 % | as of Mar 31, 2026 ↗ |
| First Trust Capital Strength ETF First Trust Exchange-Traded Fund | 1,300,578 | 181.3M $ | 2.31 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Value Discovery Fund Fidelity Devonshire Trust | 1,295,200 | 169.5M $ | 1.06 % | 0.10 % | as of Apr 30, 2026 ↗ |
| American Funds Global Balanced Fund American Funds Global Balanced Fund | 1,279,917 | 167.5M $ | 0.52 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 1,278,716 | 190.5M $ | 0.30 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Invesco S&P 500 Momentum ETF Invesco Exchange-Traded Fund Trust II | 1,270,696 | 189.3M $ | 1.41 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Large Cap Value ETF American Century ETF Trust | 1,266,513 | 188.6M $ | 1.77 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 1,256,764 | 187.2M $ | 0.20 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Dodge & Cox Balanced Fund Dodge & Cox Funds | 1,192,980 | 166.3M $ | 1.14 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 1,155,398 | 151.2M $ | 0.17 % | 0.09 % | as of Apr 30, 2026 ↗ |
| iShares Select Dividend ETF iShares Trust | 1,149,526 | 150.4M $ | 0.66 % | 0.09 % | as of Apr 30, 2026 ↗ |
| S&P 500 Index Master Portfolio Master Investment Portfolio | 1,132,142 | 157.8M $ | 0.30 % | 0.09 % | as of Mar 31, 2026 ↗ |
| JPMorgan Growth Advantage Fund J.P. Morgan Mutual Fund Investment Trust | 1,113,024 | 155.1M $ | 0.77 % | 0.09 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Equity Factor Rotation Active ETF BlackRock ETF Trust | 1,095,417 | 143.3M $ | 0.42 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 1,080,000 | 160.9M $ | 2.60 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Fidelity Equity Dividend Income Fund Fidelity Financial Trust | 1,068,000 | 159.1M $ | 1.93 % | 0.09 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro QQQ ProShares Trust | 1,067,254 | 159M $ | 0.58 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Fidelity Blue Chip Growth K6 Fund Fidelity Securities Fund | 1,054,444 | 138M $ | 0.70 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Fidelity Low-Priced Stock Fund Fidelity Puritan Trust | 1,053,115 | 137.8M $ | 0.58 % | 0.08 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Growth Account College Retirement Equities Fund | 1,051,849 | 146.6M $ | 0.39 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 1,044,646 | 136.7M $ | 0.23 % | 0.08 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 1,001,235 | 131M $ | 0.15 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Dimensional US High Profitability ETF Dimensional ETF Trust | 997,980 | 130.6M $ | 1.15 % | 0.08 % | as of Apr 30, 2026 ↗ |
| iShares S&P 500 Value ETF iShares Trust | 984,730 | 137.2M $ | 0.29 % | 0.08 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) Growth ETF SPDR SERIES TRUST | 962,282 | 134.1M $ | 0.32 % | 0.08 % | as of Mar 31, 2026 ↗ |
| VIP Equity-Income Portfolio Variable Insurance Products Fund | 903,885 | 126M $ | 1.84 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Fund Fidelity Hastings Street Trust | 899,500 | 125.4M $ | 1.49 % | 0.07 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 889,210 | 123.9M $ | 0.29 % | 0.07 % | as of Mar 31, 2026 ↗ |
| HARTFORD CORE EQUITY FUND HARTFORD MUTUAL FUNDS, INC | 880,282 | 115.2M $ | 1.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Nomura Science and Technology Fund IVY FUNDS | 854,881 | 119.1M $ | 1.92 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 841,791 | 117.3M $ | 0.88 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Blue Chip Growth Fund Fidelity Securities Fund | 839,000 | 109.8M $ | 0.62 % | 0.07 % | as of Apr 30, 2026 ↗ |
| MFS Core Equity Fund MFS SERIES TRUST I | 838,949 | 125M $ | 1.96 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Lord Abbett Growth Leaders Fund LORD ABBETT SECURITIES TRUST | 833,104 | 109M $ | 1.44 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 818,549 | 107.1M $ | 0.24 % | 0.07 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 815,631 | 106.7M $ | 0.27 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Select Fund American Century Mutual Funds, Inc. | 804,100 | 105.2M $ | 1.65 % | 0.06 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price All-Cap Opportunities Fund T. Rowe Price All-Cap Opportunities Fund, Inc. | 797,921 | 111.2M $ | 0.77 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 788,900 | 103.2M $ | 5.42 % | 0.06 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VanEck Biotech ETF VanEck ETF Trust | 14.63 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9.61 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 8.77 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.14 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.75 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 7.18 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6.48 % | as of Feb 28, 2026 ↗ |
| ProShares Nasdaq-100 Dorsey Wright Momentum ETF ProShares Trust | 5.67 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 5.42 % | as of Apr 30, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 5.40 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,336 | +84 | 506,124,423 | +3.8 % |
| 2026Q1 | 1,252 | +9 | 487,373,217 | +4.1 % |
| 2025Q4 | 1,243 | +10 | 468,305,734 | -2.6 % |
| 2025Q3 | 1,233 | +63 | 481,041,654 | -1.7 % |
| 2025Q2 | 1,170 | +100 | 489,169,265 | -2.9 % |
| 2025Q1 | 1,070 | +12 | 503,775,731 | +0.8 % |
| 2024Q4 | 1,058 | +35 | 499,619,246 | +0.5 % |
| 2024Q3 | 1,023 | -35 | 497,084,977 | -0.4 % |
| 2024Q2 | 1,058 | -30 | 498,997,563 | -0.2 % |
| 2024Q1 | 1,088 | -47 | 500,069,973 | -0.5 % |
| 2023Q4 | 1,135 | 502,399,825 |
Institutional managers
2,285 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 119,010,973 | 16.6B $ | as of Mar 31, 2026 |
| FMR LLC | 71,906,290 | 10B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 59,858,585 | 8.3B $ | as of Mar 31, 2026 |
| Capital World Investors | 41,283,933 | 5.8B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 33,992,410 | 4.6B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 29,726,052 | 4.1B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 27,127,533 | 3.8B $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 26,248,108 | 3.7M $ | as of Mar 31, 2026 |
| Dodge & Cox | 24,250,826 | 3.4B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 23,299,295 | 3.2B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 19,978,936 | 2.8B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 15,526,336 | 2.2B $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 15,053,151 | 2.1B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 13,820,379 | 1.9B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 13,537,991 | 1.9B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 13,199,103 | 1.8B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 11,065,214 | 1.5B $ | as of Mar 31, 2026 |
| Amundi | 10,539,111 | 1.5B $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 10,464,889 | 1.5B $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8,181,780 | 1.1B $ | as of Mar 31, 2026 |
| Nuveen, LLC | 7,833,564 | 1.1B $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 7,722,929 | 1.1B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 7,287,230 | 1B $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 6,628,441 | 923.8M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 6,281,609 | 909.7M $ | as of Mar 31, 2026 |
Declared shareholders of Gilead Sciences Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.51 % | 93,327,127 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Gilead Sciences Inc
288 funds declare 1,016 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Gilead Sciences Inc". https://titelia.com/en/stocks/gilead-sciences-inc-US3755581036